CHF9.80
1.01%
SIX Swiss Exchange, Oct 09, 05:30 pm CEST. Closed.
ISIN
CH0461929603
Symbol
XLS

Xlife Sciences Stock price

CHF9.80
-4.90 33.33% 1M
-11.70 54.42% 6M
-14.90 60.32% YTD
-10.90 52.66% 1Y
-30.20 75.50% 3Y
-42.20 81.15% 5Y
-42.20 81.15% 10Y
-42.20 81.15% 20Y
SIX Swiss Exchange, Closing price Fri, Oct 09 2026
-0.10 1.01%

Is Xlife Sciences a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,113 stocks worldwide.

Key metrics

Basic
Market capitalization
CHF56.2m
Enterprise Value
CHF115.8m
Net debt
CHF59.5m
Cash
CHF1.1m
Shares outstanding
5.8m
Valuation
P/E
-
P/S | estimate
- | -
EV/Sales | estimate
- | -
EV/FCF | ex SBC
negative | -
P/B
0.2
Financial Health
Equity Ratio
55.4%
Return on Equity
-7.5%
ROCE
-
ROIC
-
Debt/Equity
0.2
Financials
Revenue | estimate
- | CHF0.0
EBITDA
-
EBIT
-
Net Income
-
Free Cash Flow | ex SBC
CHF-1.3m | -
Growth
Revenue | estimate
- | -100.0%
EBITDA
-
EBIT
-
Net Income
-
Free Cash Flow
-197.7%
Margin
Gross
-
EBITDA
-
EBIT
-
Net
-
Free Cash Flow | ex SBC
- | -
More
EPS
-
FCF per Share
CHF-0.2
Short interest
-
Employees
20
Rev per Employee
CHF10.0k

Xlife Sciences Stock Analysis

Unlock Scores for Free

Analyst Opinions

5 Analysts have issued a Xlife Sciences forecast:

4x Buy
80%
1x Hold
20%

Analyst Opinions

5 Analysts have issued a Xlife Sciences forecast:

Buy
80%
Hold
20%

Financial data from Xlife Sciences

Jun '25
+/-
%
0.84 0.84
15% 15%
100%
- Direct Costs 0.32 0.32
29% 29%
38%
0.52 0.52
4% 4%
62%
- Selling and Administrative Expenses 4.48 4.48
25% 25%
533%
- Research and Development Expense - -
-
-
-3.36 -3.36
27% 27%
-400%
- Depreciation and Amortization 16 16
0% 0%
1,917%
EBIT (Operating Income) EBIT -19 -19
4% 4%
-2,316%
Net Profit 31 31
45% 45%
3,661%

In millions CHF.

Don't miss a Thing! We will send you all news about Xlife Sciences directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Xlife Sciences AG focuses on the value development of performance promising technologies in life sciences. The company is headquartered in Zurich, Switzerland.

Head office Switzerland
CEO Oliver Baumann
Employees 20
Website www.xlifesciences.ch

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today